PerkinElmer Names New Chief Marketing Officer

PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced the appointment of Lapo Paladini, PhD, to the newly created position of chief marketing officer and senior vice president.

The new chief marketing officer position will be responsible for leading PerkinElmer's marketing organization, as well as developing and implementing key aspects of the Company's long-term market strategy, including marketing and channel strategy and corporate communications.

"The new CMO position is a critical component of our market-focused approach in Human and Environmental Health,” said Robert Friel, chairman and CEO of PerkinElmer, Inc. "We are excited to utilize Lapo’s deep knowledge and insights into customer requirements in numerous and differing markets throughout the world, most recently in Asia Pacific and South America, to drive our market strategy and increase our business in high growth areas.”

Prior to this new appointment, Paladini served as president, Asia Pacific, East Europe, Middle East and Africa and South America for PerkinElmer. Since joining PerkinElmer in February 1982, he has held a succession of management positions in the Company, including vice president and general manager, sales and service, Europe, for PerkinElmer Analytical Instruments, and global sales and marketing leader for PerkinElmer Life and Analytical Sciences.

Paladini holds a doctorate in industrial chemistry from the University of Pisa, Italy.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2 billion in 2008, has around 8,500 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products decline or do not grow as anticipated; (2) global economic, political and other risks; (3) our failure to introduce new products in a timely manner; (4) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable; (5) our failure to adequately protect our intellectual property; (6) the loss of any of our licenses or licensed rights; (7) our ability to compete effectively; (8) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (9) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (10) disruptions in the supply of raw materials, key components and supplies; (11) the manufacture and sale of products may expose us to product liability claims; (12) our failure to maintain compliance with applicable government regulations; (13) regulatory changes; (14) our failure to comply with health care industry regulations; (15) economic, political and other risks associated with foreign operations; (16) our ability to retain key personnel; (17) significant disruption in our information technology systems or the failure to successfully implement new systems; (18) restrictions in our credit agreements; (19) our ability to realize the full value of our intangible assets; (20) significant fluctuations in our stock price; (21) dividends we pay on our stock could be reduced or eliminated in the future; and (22) other factors which we describe under the caption "Risk Factors" in our most recent annual report on Form 10-K and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6013940&lang=en